Solventum Co. (NYSE:SOLV) Shares Purchased by MML Investors Services LLC

MML Investors Services LLC raised its stake in Solventum Co. (NYSE:SOLV) by 3.2% during the third quarter, Holdings Channel.com reports. The firm owned 5,345 shares of the company’s stock after purchasing an additional 168 shares during the quarter. MML Investors Services LLC’s holdings in Solventum were worth $373,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Copeland Capital Management LLC acquired a new stake in Solventum during the 3rd quarter worth $26,000. Mather Group LLC. acquired a new stake in shares of Solventum during the third quarter worth about $27,000. Hollencrest Capital Management purchased a new stake in shares of Solventum in the 2nd quarter valued at about $25,000. True Wealth Design LLC boosted its position in shares of Solventum by 23,550.0% in the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company’s stock valued at $33,000 after purchasing an additional 471 shares during the period. Finally, Deseret Mutual Benefit Administrators acquired a new stake in shares of Solventum in the 2nd quarter valued at about $25,000.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on SOLV. Morgan Stanley upped their price objective on shares of Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research report on Monday, November 11th. Piper Sandler lifted their price objective on Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a report on Friday, November 8th. BTIG Research started coverage on Solventum in a research note on Thursday, September 5th. They set a “neutral” rating for the company. Stifel Nicolaus assumed coverage on Solventum in a research note on Tuesday, October 8th. They issued a “buy” rating and a $82.00 price target on the stock. Finally, Wolfe Research started coverage on Solventum in a report on Thursday, September 26th. They set a “peer perform” rating on the stock. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, Solventum has a consensus rating of “Hold” and a consensus price target of $68.29.

Solventum Trading Down 0.1 %

Shares of SOLV opened at $66.56 on Wednesday. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. The firm’s 50 day moving average is $70.84 and its 200-day moving average is $63.69. Solventum Co. has a 12-month low of $47.16 and a 12-month high of $96.05.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.